Sun Pharmaceutical Industries Ltd , country's largest drugmaker by sales, reported a 13.6% drop in its fourth-quarter profit due to slow sales in the United States.
The Mumbai-based company reported a January-March net profit of Rs 1,224 crore, compared with Rs 1,416 crore a year earlier.
The board recommends dividend of Rs 3.5 per share.